[ACRS] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
15-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -7.30%
YoY- -143.42%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,580 1,095 3,669 999 0 0 0 -
PBT -13,779 -19,177 -38,551 -24,764 -11,475 -4,714 -2,597 32.03%
Tax -182 -32,181 -958 -1,830 -40 -33 0 -
NP -13,173 -18,594 -38,551 -22,934 -11,475 -4,714 -2,597 31.04%
Tax Rate - - - - - - - -
Total Cost 14,753 19,689 42,220 23,933 11,475 4,714 2,597 33.54%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -833.73 -1,698.08 -1,050.72 -2,295.70 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.30 -0.45 -0.99 -0.74 -0.49 -0.26 -0.24 3.78%
EPS Diluted -0.30 -0.45 -0.99 -0.74 -0.49 -0.26 -0.24 3.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.